Marinus Pharmaceuticals signs collaboration deal worth up to $266M with Chinese biotech firm

The deal involving an anti-seizure medicine includes a $10 million upfront payment.

Marinus Pharmaceuticals signs collaboration deal worth up to $266M with Chinese biotech firm
The deal involving an anti-seizure medicine includes a $10 million upfront payment.